Hormonal
Selective reduction of dietary fat (but not carbohydrate) in adults with obesity decreases striatal dopamine D2/3 receptor binding potential and neural activity to food cues, leading to increased consumption of hyperpalatable foods high in both fat and carbohydrate.
If you are trying to lose weight by cutting fat, be aware that your brain may biologically respond by increasing the 'reward signal' (dopamine) for high-fat, high-carb foods. This doesn't mean you lack willpower; it means your brain is signaling a stronger desire for those specific foods. To counter this, you might need to be extra mindful of hyperpalatable foods (high sugar + high fat) when following a low-fat diet, as your brain may be primed to seek them out more aggressively than if you had restricted carbohydrates instead.
Reduction of dietary fat, but not carbohydrate, decreased D2BP and decreased neural activity to food cues in brain reward regions. After the reduced fat diet, ad libitum intake shifted towards foods high in both fat and carbohydrates.
Why this rating
Randomized crossover trial with rigorous inpatient metabolic ward controls and multimodal neuroimaging (PET/fMRI), though limited to short-term (5 days) effects.
Source
Restriction of dietary fat, but not carbohydrate, affects brain reward regions in adults with obesity
Valerie L. Darcey et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022
DOI 10.1101/2022.04.19.488800
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →